FN2 Earnings Intelligence

NIKE, Inc. earnings overview

Latest NIKE, Inc. (NKE) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportNIKE, Inc. reports Thursday, Dec 17, 2026 · After market closeConsensus EPS $0.36 · consensus revenue $11.13B
NKE FY2027 Q1 · Calendar Q4 2026

NIKE, Inc.

Nike’s performance categories show evidence of product and marketing traction, but the broader recovery remains unproven: Sportswear, Jordan, and Greater China are under pressure, while the Pace transformation and inventory reset must be executed before that traction can support a durable earnings recovery.

EPS surprise+10.0%
Market move-0.7%
NKE FY2026 Q4 · Calendar Q2 2026

NIKE, Inc.

Nike's Q4 was boosted by a one-time $986M tariff recovery that drove a large EPS beat, but the core business remains in transition. Performance categories delivered mid single-digit growth and market-share gains, while sportswear and Jordan streetwear saw double-digit sell-through declines. Management lowered FY27 revenue guidance to a low-to-mid single-digit decline, though gross margin expansion is expected. Shares rose 5% on the print.

EPS surprise+554.5%
Market move+4.9%
NKE FY2026 Q3 · Calendar Q1 2026

NIKE, Inc.

The quarter provides mixed evidence for a durable recovery: product innovation, Running and football growth, and North America wholesale momentum support the case, but inventory cleanup, Sportswear weakness, tariffs, promotions, and weaker Direct performance continue to constrain revenue and margins.

EPS surprise+20.4%
Market move-15.5%
NKE FY2026 Q2 · Calendar Q4 2025

NIKE, Inc.

The supplied analysis supports a mixed earnings picture: wholesale and running momentum provide evidence of demand resilience, but tariff costs, Greater China challenges and the uncertain path to margin recovery limit the strength of the growth case.

EPS surprise+41.4%
Market move-10.5%
NKE FY2026 Q1 · Calendar Q3 2025

NIKE, Inc.

Nike's latest analysis supports a mixed recovery case: running growth, North America wholesale momentum, and product launches are constructive, but tariff-driven margin pressure, Greater China weakness, and no expected Nike Direct growth this year leave the turnaround unproven.

EPS surprise+80.1%
Market move+6.4%
NKE FY2025 Q4 · Calendar Q2 2025

NIKE, Inc.

The evidence is mixed but improving: management described early benefits from sport-led product launches, organizational changes, and a stronger wholesale order book, while the earnings profile still faces tariff, inventory, classic-footwear, digital-traffic, and Greater China headwinds. The current analysis supports a cautious recovery thesis rather than a full turnaround.

EPS surprise+7.4%
Market move+15.2%
NKE FY2025 Q3 · Calendar Q1 2025

NIKE, Inc.

Nike’s Q3 analysis supports a mixed transition thesis: performance innovation and a full-price marketplace reset provide potential recovery levers, but inventory, classic-franchise weakness, and macro pressures continue to weigh on the near-term trajectory.

EPS surprise—
Market move-5.5%
NKE FY2025 Q2 · Calendar Q4 2024

NIKE, Inc.

The call supports a conditional case for a recovery rather than a confirmed inflection: management is redirecting Nike toward sport-led innovation, premium pricing, and stronger wholesale execution, but inventory, discounting, and declining classic franchises remain material obstacles.

EPS surprise—
Market move-0.2%

Get the NKE recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.